ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.891,68
-0,53%
S&P 500
5.667,56
0,08%
Dow Jones
41.985,35
0,08%
Euro vs US Dollar
1,08745
-0,01%
Bitcoin
84.257,75
0,25%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Edgewise Therapeutics Inc (EWTX)

  7. Edgewise Therapeutics Inc (EWTX) News

EWTX

Edgewise Therapeutics (EWTX)

Edgewise Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EWTX
DatumZeitQuelleÜberschriftSymbolFirma
11/03/202521h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EWTXEdgewise Therapeutics Inc
03/03/202514h05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EWTXEdgewise Therapeutics Inc
03/03/202514h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EWTXEdgewise Therapeutics Inc
03/03/202514h00Business WireEdgewise Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsNASDAQ:EWTXEdgewise Therapeutics Inc
07/02/202522h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EWTXEdgewise Therapeutics Inc
07/02/202522h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EWTXEdgewise Therapeutics Inc
05/02/202522h19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EWTXEdgewise Therapeutics Inc
05/02/202522h09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EWTXEdgewise Therapeutics Inc
03/02/202522h36Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:EWTXEdgewise Therapeutics Inc
24/01/202501h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EWTXEdgewise Therapeutics Inc
24/01/202501h56Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EWTXEdgewise Therapeutics Inc
22/01/202514h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EWTXEdgewise Therapeutics Inc
22/01/202514h00Business WireEdgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical DevelopmentNASDAQ:EWTXEdgewise Therapeutics Inc
13/01/202514h00Business WireEdgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025NASDAQ:EWTXEdgewise Therapeutics Inc
07/01/202514h00Business WireEdgewise Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025NASDAQ:EWTXEdgewise Therapeutics Inc
31/12/202423h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EWTXEdgewise Therapeutics Inc
30/12/202422h10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EWTXEdgewise Therapeutics Inc
16/12/202423h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EWTXEdgewise Therapeutics Inc
16/12/202412h00Business WireEdgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker)NASDAQ:EWTXEdgewise Therapeutics Inc
05/12/202420h32Business WireEdgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease ResearchNASDAQ:EWTXEdgewise Therapeutics Inc
26/11/202412h00Business WireEdgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024NASDAQ:EWTXEdgewise Therapeutics Inc
07/11/202414h53Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EWTXEdgewise Therapeutics Inc
07/11/202414h07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EWTXEdgewise Therapeutics Inc
07/11/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EWTXEdgewise Therapeutics Inc
07/11/202414h00Business WireEdgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:EWTXEdgewise Therapeutics Inc
01/10/202414h00Business WireEdgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle SocietyNASDAQ:EWTXEdgewise Therapeutics Inc
25/09/202402h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EWTXEdgewise Therapeutics Inc
25/09/202402h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EWTXEdgewise Therapeutics Inc
20/09/202422h46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EWTXEdgewise Therapeutics Inc
20/09/202422h29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EWTXEdgewise Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:EWTX

Kürzlich von Ihnen besucht

COIN
ACATGBP
Alphacat
AQSE
ZPHR.GB
Zephyr Energy
AMEX
VGK
Vanguard FTSE Europe
EU
CACT
CAC All Tradeable
NYSE
QXM
COIN
GOALUSD
Goal Bonanza
COIN
APEDUSD
Aped
EU
XIOR
Xior Student Housing NV
TSXV
BTV
BlueRush
EU
REAL
Realco NV
AMEX
RGI
Invesco S&P 500 Equal We...
BIT
WCOE
ETF
COIN
EGCCUSD
Engine Token
EU
BELS
Bel Small
LSE
0OHB
Yuri Gagarin Ad
COIN
MITHUSD
Mithril
Delayed Upgrade Clock
ADVFN Logo
Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten